20069 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
PEPTIDE-LIPID CONJUGATES AND APPLICATION THEREOF
#2DRUG DELIVERY METHODS AND COMPOSITIONS
#3RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL
#4MODIFIED APOLIPOPROTEINS WITH A TARGETING BODY FOR LIPID NANOPARTICLES
#5COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS
#6METHOD FOR SYNTHESIZING HYBRID NANOPARTICLES COMPRISING APOLIPOPROTEINS
#7NUCLEIC ACID ENCODED TRANSCRIPTION FACTOR INHIBITORS
#8INTERNALLY FIXED LIPID VESICLE
#9CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS
#10PROTEOLIPOSOMES COMPRISING A SARS-COV-2 S GLYCOPROTEIN ECTODOMAIN AND THEIR USE AS A VACCINE
#11HYDROPHOBIC DRUGS IN ORGANIC CORE HIGH DENSITY LIPOPROTEIN (HDL) NANOPARTICLES
#12Myelin Nanovesicles And Uses Thereof
#13LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#14Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#15LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
#16PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES
#17NOVEL RECONSTITUTED HIGH DENSITY LIPOPROTEIN NANOPARTICLE
#18IPA-3-loaded liposomes and methods of use thereof
#19PEPTIDE-LIPID CONJUGATES
#20SYNERGISTIC IMMUNOSTIMULATION THROUGH THE DUAL ACTIVATION OF TLR3/9 WITH SPHERICAL NUCLEIC ACIDS
#21PROTEIN STABILIZED LIPOSOMES (PSL) AND METHODS OF MAKING THEREOF
#22MULTIVESICULAR LIPOSOME FORMULATIONS OF DEXMEDETOMIDINE
#23Drug delivery methods and compositions
#24MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF
#25PRODUCTION OF SALIPRO PARTICLES
#26HIGH DENSITY LIPOPROTEIN MIMETIC NANOPARTICLES USING LIPID CONJUGATED CORE SCAFFOLDS
#27Reconstituted high density lipoprotein formulation and production method thereof
#28Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
#29EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS
#30TLR7/8 AGONISTS AND LIPOSOME COMPOSITIONS
#31Liposomal-gold nanoparticles for drug delivery into the brain
#32IPA-3-loaded liposomes and methods of use thereof
#33Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
#34LUNG SURFACTANT-BASED ANTICANCER DRUG
#35Compartmentalised gel matrix and method of production
#36Compositions and methods for delivery of biomacromolecule agents
#37LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#38Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant
#39Surface display of antigens on Gram-negative outer membrane vesicles
#40METHODS OF IMPROVING EFFICACY OF ALLERGY VACCINES
#41Reconstituted high density lipoprotein formulation and production method thereof
#42Methods for treatment of nephrotic syndrome and related conditions
#43Cholestosome vesicles for incorporation of molecules into chylomicrons
#44Remote loading of sparingly water-soluble drugs into liposomes
#45NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR IMPROVED DRUG LOADING
#46Preparation method of adiposomes, and use thereof
#47Internally fixed lipid vesicle
#48MICROFLUIDIC-FORMULATED LEUKOSOME COMPOSITIONS AND FABRICATION METHODS THEREFOR
#49Remote loading of sparingly water-soluble drugs into liposomes
#50LIPOPROTEINS CONTAINING PLATINUM COMPLEXES FOR THE TREATMENT OF CANCER
#51Biodegradable compound, lipid particle, composition containing lipid particle, and kit
#52APO-E MODIFIED LIPID NANOPARTICLES FOR DRUG DELIVERY TO TARGETED TISSUES AND THERAPEUTIC METHODS
#53Detection apparatus for differential-charged particle mobility analyzer
#54Engineered exosomes for the delivery of bioactive cargo using transmembrane VSV-G
#55Dried saponin liposomal composition
#56Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#57SALIPRO PARTICLES
#58Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#59Surface display of antigens on gram-negative outer membrane vesicles
#60Cholestosome vesicles for incorporation of molecules into chylomicrons
#61VITRO RELEASE ASSAY FOR LIPOSOME ENCAPSULATED VINCRISTINE
#62NANOPARTICLES FOR LIPID HOMEOSTASIS
#63REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES
#64Reconstituted high density lipoprotein formulation and production method thereof
#65Cancer targeting by anti-EGFR peptides and applications thereof
#66Charged lipoprotein complexes and their uses
#67COMPOSITION OF LIPID-BASED NANOPARTICLES FOR SMALL MOLECULES AND MACROMOLECULES
#68Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#69Methods for treatment of nephrotic syndrome and related conditions
#70Remote loading of sparingly water-soluble drugs into liposomes
#71HDL comprising a therapeutic agent and use in therapy
#72Cationic lipid formulations for regressing established tumor
#73Detection apparatus for differential-charged particle mobility analyzer
#74RECONSTITUTED HIGH DENSITY LIPOPROTEINS COMPOSITION AND USES THEREOF
#75CELL PENETRATING PEPTIDE INTRODUCED DRUG-DELIVERY CARRIER COMPRISING MACROMOLECULE
#76Salipro particles
#77Cholestosome vesicles for incorporation of molecules into chylomicrons
#78Reconstituted high density lipoprotein formulation and production method thereof
#79Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
#80In vitro release assay for liposome encapsulated vincristine
#81Nanoscale Bound Bilayers, Methods of Use and Production
#82METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE
#83Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
#84REGULATING THE INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYL SERINE
#85LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS
#86Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
#87Liposomes active in-vivo on neurodegenerative diseases
#88ORAL DOSAGE FORM OF TETRAHYDROCANNABINOL AND A METHOD OF AVOIDING AND/OR SUPPRESSING HEPATIC FIRST PASS METABOLISM VIA TARGETED CHYLOMICRON/LIPOPROTEIN DELIVERY
#89PKC activators and combinations thereof
#90Endothelium protective materials and methods of use
#91Lipid therapy
#92Charged lipoprotein complexes and their uses
#93Methods for treatment of nephrotic syndrome and related conditions
#94LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS
#95Liposomes active in-vivo on neurodegenerative diseases
#96Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof
#97Nanostructure suitable for sequestering cholesterol and other molecules
#98Reconstituted high density lipoprotein formulation and production method thereof
#99Telodendrimer nanodiscs without apolipoprotein
#100LIPID FORMULATED SINGLE STRANDED RNA
#101Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#102Charged lipoprotein complexes and their uses
#103COMPOSITIONS AND METHODS FOR DELIVERING RNAI USING APOE
#104METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE
#105Method of reducing side effects associated with administration of tissue plasminogen activator (tPA)
#106NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE
#107AMPHIPHILIC STAR-LIKE OR SCORPION-LIKE MACROMOLECULES, VARIOUS COMPOSITIONS AND USES THEREOF
#108Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#109IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS
#110Use of Green Porphyrins to Treat Neovasculature in the Eye
#111COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
#112Nanoscale bound bilayers, methods of use and production
#113Nanostructures suitable for sequestering cholesterol and other molecules
#114Spontaneously Forming Ellipsoidal Phospholipid Unilamellar Vesicles
#115LDL-LIKE CATIONIC NANOPARTICLES FOR DELIVERYING NUCLEIC ACID GENE, METHOD FOR PREPARING THEREOF AND METHOD FOR DELIVERYING NUCLEIC ACID GENE USING THE SAME
#116Synthetic LDL as targeted drug delivery vehicle
#117Nanostructures Suitable for Sequestering Cholesterol and Other Molecules
#118Targeted cancer chemotherapy using synthetic nanoparticles
#119RLIP76 liposomes for protection against irradiation
#120Camptothecin-analog with a novel, “flipped” lactone-stable, E-ring and methods for making and using same
#121Use of green porphyrins to treat neovasculature in the eye
#122Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#123Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#124Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#125Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#126Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
#127Amphiphilic Star-Like Or Scorpion-Like Macromolecules, Various Compositions And Uses Threof
#128Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
#129Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
#130Lipid therapy
#131Peptide/Lipid Complex Formation by Co-Lyphilization
#132Targeting endothelium for tissue-specific delivery of agents
#133Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
#134Particulate formulations for intradermal delivery of biologically active agents
#135Use of green porphyrins to treat neovasculature in the eye
#136Charged lipoprotein complexes and their uses
#137Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#138Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis
#139Use of green porphyrins to treat neovasculature in the eye
#140Emulsion formulations for hydrophilic active agents
#141Liposomes for protection against toxic compounds
#142Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#143Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
#144Detection apparatus for differential-charged particle mobility analyzer